Celiac disease drugs seem to be improving over the years with continuous research and development activities across the globe
For a long time, those diagnosed with celiac disease had no celiac disease drugs for them. These were the types of treatments that were recommended by physicians and others who are knowledgeable about this condition. It was believed for a long time that those diagnosed would simply have to live with their condition and avoid certain things. No one really understood the nature of this disorder. However, recent advances in celiac disease drugs have been made. This has been very important as the number of people with this disorder continues to rise. As per the Celiac India Organization, the prevalence of the celiac disease across the globe is around 1%.
Currently, there are two general categories of celiac disease drugs. One of these is a type that has been available for decades. These are the more conventional forms of treatment. In addition to a gluten-free diet, these drugs involve dietary modifications. This includes removing wheat and other foods from the diet that have been proven to be sources of gluten. Another category of celiac disease drugs is represented by enzyme blockers. These are used primarily to treat those with more advanced stages of the condition. The use of this medication can also help to keep the weight under control and help to maintain a lifelong gluten-free diet. The effects of obesity are all too well known.
Lastly, there is the gluten-free diet medication, which is the last part of the celiac disease drug pipeline report. This type of medicine has been tested in the lab and will continue to progress through clinical trials. As of right now, there are no known side effects associated with this medication. However, any potential side effects will need to be tested in a double-blind clinical trial. Recently, in August 2020, Provention Bio Inc., a biopharmaceutical company, imitated Phase IIB Proactive study of PRV-015 (anti-IL-15) in non-responsive celiac disease.
